These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24482919)

  • 1. [Osteoporosis therapy. Drugs for strong bones].
    MMW Fortschr Med; 2013 Nov; 155(20):26. PubMed ID: 24482919
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures .
    Meijer WM; Penning-van Beest FJ; Olson M; Herings RM
    Curr Med Res Opin; 2008 Nov; 24(11):3217-22. PubMed ID: 18922215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Wildpaner D; Pavese C; Weber M
    Praxis (Bern 1994); 2017 Apr; 106(8):421-427. PubMed ID: 28401777
    [No Abstract]   [Full Text] [Related]  

  • 4. Denosumab (prolia) for treatment of postmenopausal osteoporosis.
    Johnson GL
    Am Fam Physician; 2012 Feb; 85(4):334-6. PubMed ID: 22335312
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):203-210. PubMed ID: 29232356
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison table: some drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Jun; 59(1523):e104-e106. PubMed ID: 28609428
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison table: Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Dec; 59(1536):e210-e212. PubMed ID: 29232357
    [No Abstract]   [Full Text] [Related]  

  • 8. Real-world challenges of treating osteoporosis.
    Owens G
    Am J Manag Care; 2011 May; 17 Suppl 6():S177-84. PubMed ID: 21882487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Denosumab--a new efficient osteoporosis therapy].
    Rejnmark L; Vestergaard P; Mosekilde L
    Ugeskr Laeger; 2011 Jan; 173(5):346-9. PubMed ID: 21276398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
    Josse R; Khan A; Ngui D; Shapiro M
    Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACOG Practice Bulletin N. 129. Osteoporosis.
    Committee on Practice Bulletins-Gynecology, The American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2012 Sep; 120(3):718-34. PubMed ID: 22914492
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial.
    Montori VM; Shah ND; Pencille LJ; Branda ME; Van Houten HK; Swiglo BA; Kesman RL; Tulledge-Scheitel SM; Jaeger TM; Johnson RE; Bartel GA; Melton LJ; Wermers RA
    Am J Med; 2011 Jun; 124(6):549-56. PubMed ID: 21605732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

  • 14. Bones, heart and the new anabolic agent romosozumab.
    Pazianas M
    Postgrad Med J; 2019 Oct; 95(1128):521-523. PubMed ID: 31422376
    [No Abstract]   [Full Text] [Related]  

  • 15. Abaloparatide (Tymlos) for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2017 Jun; 59(1523):97-98. PubMed ID: 28609423
    [No Abstract]   [Full Text] [Related]  

  • 16. 2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong.
    ; Ip TP; Lee CA; Lui TD; Wong RMY; Cheung CL; Chiu KCP; Chow SLE; Ho CF; Ho TC; Ho YA; Lee KK; Li HR; Mak KC; Ng KD; Ngai SLI; Wong CG; Wong SJ; Wong SH; Wong TW
    Hong Kong Med J; 2024 Apr; 30 Suppl 2():1-44. PubMed ID: 39113555
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversies in osteoporosis management: how do you treat a newly menopausal woman with low bone mass: when and how is it appropriate to provide pharmacologic intervention to prevent osteoporosis?
    Jiang X; Kagan R; Schnatz PF
    Clin Obstet Gynecol; 2013 Dec; 56(4):739-42. PubMed ID: 24022501
    [No Abstract]   [Full Text] [Related]  

  • 18. [Osteoporosis in the man: broad indication for strontium ranelate].
    MMW Fortschr Med; 2012 Nov; 154(21):86-7. PubMed ID: 23270063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Promises and fears of osteoporosis treatments].
    Uebelhart B
    Rev Med Suisse; 2013 Jan; 9(371):262. PubMed ID: 23451595
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for osteoporosis: recommendation statement.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2011 May; 83(10):1197-200. PubMed ID: 21568254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.